Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • Tehran University of Medical Sciences and Health Services (46131)

This publication has 62 references indexed in Scilit: